ArticleJournal of managed care & specialty pharmacy2024

Cost-effectiveness of eculizumab and efgartigimod for the treatment of anti-acetylcholine receptor antibody-positive generalized myasthenia gravis.

Pei-Wen Lien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.